Flagship Harbor Advisors, LLC Biogen Inc. Transaction History

Flagship Harbor Advisors, LLC

$1.82 Billion
Q4 2024

A detailed history of Flagship Harbor Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Flagship Harbor Advisors, LLC holds 1,553 shares of BIIB stock, worth $224,268. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,553

Previous 1,398 11.09%

Holding current value

$224,268

Previous $270,000 12.22%

% of portfolio

0.01%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	BUY	$146.47 - $191.55 $22,702 - $29,690	155 Added 11.09%	1,553 $237,000
Q3 2024 Oct 21, 2024	BUY	$189.07 - $236.8 $3,781 - $4,736	20 Added 1.45%	1,398 $270,000
Q1 2024 Apr 16, 2024	SELL	$212.02 - $267.71 $53,641 - $67,730	-253 Reduced 15.51%	1,378 $297,000
Q4 2023 Jan 10, 2024	SELL	$222.59 - $267.94 $6,677 - $8,038	-30 Reduced 1.81%	1,631 $422,000
Q3 2023 Oct 17, 2023	BUY	$253.3 - $285.89 $32,929 - $37,165	130 Added 8.49%	1,661 $426,000
Q2 2023 Jul 11, 2023	SELL	$275.25 - $318.06 $4,954 - $5,725	-18 Reduced 1.16%	1,531 $436,000
Q1 2023 Apr 12, 2023	BUY	$256.56 - $292.34 $397,411 - $452,834	1,549 New	1,549 $430,000
Q1 2022 Apr 13, 2022	SELL	$193.77 - $244.14 $180,399 - $227,294	-931 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $69,639 - $89,496	-311 Reduced 25.04%	931 $223,000
Q2 2021 Jul 26, 2021	SELL	$259.0 - $414.71 $61,901 - $99,115	-239 Reduced 16.14%	1,242 $430,000
Q1 2021 May 03, 2021	SELL	$242.95 - $284.63 $114,915 - $134,629	-473 Reduced 24.21%	1,481 $414,000
Q4 2020 Feb 08, 2021	SELL	$236.26 - $355.63 $121,201 - $182,438	-513 Reduced 20.79%	1,954 $478,000
Q3 2020 Oct 13, 2020	SELL	$264.77 - $305.71 $74,135 - $85,598	-280 Reduced 10.19%	2,467 $699,000
Q2 2020 Jul 31, 2020	BUY	$258.66 - $342.55 $252,452 - $334,328	976 Added 55.11%	2,747 $734,000
Q1 2020 May 12, 2020	SELL	$268.85 - $341.04 $7,796 - $9,890	-29 Reduced 1.61%	1,771 $560,000
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $44,892 - $62,030	204 Added 12.78%	1,800 $534,000
Q3 2019 Oct 22, 2019	SELL	$217.44 - $243.88 $241,140 - $270,462	-1,109 Reduced 41.0%	1,596 $371,000
Q2 2019 Jul 22, 2019	SELL	$219.29 - $241.72 $53,506 - $58,979	-244 Reduced 8.27%	2,705 $632,000
Q1 2019 Apr 15, 2019	BUY	$216.71 - $338.96 $22,104 - $34,573	102 Added 3.58%	2,949 $697,000
Q4 2018 Jan 28, 2019	BUY	$278.5 - $352.75 $121,147 - $153,446	435 Added 18.03%	2,847 $856,000
Q3 2018 Nov 05, 2018	BUY	$293.51 - $383.83 $2,348 - $3,070	8 Added 0.33%	2,412 $850,000
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $3,090 - $3,682	12 Added 0.5%	2,404 $697,000
Q1 2018 Apr 24, 2018	BUY	$260.13 - $367.91 $110,555 - $156,361	425 Added 21.61%	2,392 $642,000
Q4 2017 Jan 24, 2018	BUY	$307.64 - $344.58 $15,689 - $17,573	51 Added 2.66%	1,967 $647,000
Q3 2017 Oct 23, 2017	SELL	$281.15 - $329.69 $20,242 - $23,737	-72 Reduced 3.62%	1,916 $629,000
Q2 2017 Aug 09, 2017	BUY	N/A	1,988	1,988 $543,000

Others Institutions Holding BIIB

# of Institutions

1,000

Shares Held

130M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.

Account

Flagship Harbor Advisors, LLC Biogen Inc. Transaction History